1. Academic Validation
  2. Biological evaluation, molecular modeling and dynamics simulation of phenanthrenes isolated from Bletilla striata as butyrylcholinesterase inhibitors

Biological evaluation, molecular modeling and dynamics simulation of phenanthrenes isolated from Bletilla striata as butyrylcholinesterase inhibitors

  • Sci Rep. 2022 Aug 11;12(1):13649. doi: 10.1038/s41598-022-17912-7.
Yi Liu 1 Yanbei Tu 2 Yunyao Kang 1 Chao Zhu 1 Chuanhai Wu 1 Gang Chen 3 4 Zerong Liu 3 4 Yanfang Li 5
Affiliations

Affiliations

  • 1 School of Chemical Engineering, Sichuan University, Chengdu, 610065, China.
  • 2 School of Pharmacy, Jiangsu University, Zhenjiang, 212013, Jiangsu, China.
  • 3 Central Nervous System Drug Key Laboratory of Sichuan Province, Luzhou, 646106, China.
  • 4 Sichuan Credit Pharmaceutical CO., Ltd., Luzhou, 646106, China.
  • 5 School of Chemical Engineering, Sichuan University, Chengdu, 610065, China. lyf471@vip.163.com.
Abstract

As part of our continuous studies on natural cholinesterase inhibitors from plant kingdom, the 95% ethanol extract from tubers of Bletilla striata showed promising butyrylcholinesterase (BChE) inhibition (IC50 = 8.6 μg/mL). The extracts with different polarities (petroleum ether, ethyl acetate, n-butanol, and water) were prepared and evaluated for their inhibition of cholinesterases. The most active ethyl acetate extract was subjected to a bioassay-guided isolation and afforded twenty-two bibenzyls and phenanthrenes (1-22). All isolates were further evaluated for their BChE inhibition activity, and five phenanthrenes presented promising capacity (IC50 < 10 μM). Further kinetic studies indicated their modes of inhibition. Compounds 6, 8, and 14 were found to be mixed-type inhibitors, while compounds 10 and 12 could be classified as non-competitive inhibitors. The potential interaction mechanism of them with BChE was demonstrated by molecular docking and molecular dynamics simulation, showing that they could interact with catalytic active site and peripheral anionic site of BChE. These natural phenanthrenes provide new scaffold for the further design and optimization, with the aim to discover new selective BChE inhibitors for the treatment of AD.

Figures
Products